GLP-RT

Maximized Weight Loss: In Phase 2 clinical data, GLP-RT demonstrated unprecedented weight reduction, with participants losing up to 24.2% of their total body weight over 48 weeks—the highest efficacy recorded to date in the peptide class.

Direct Fat Oxidation: By stimulating the Glucagon receptor, GLP-RT signals the body to increase energy expenditure and actively "burn" stored adipose tissue, rather than just reducing caloric intake.

Comprehensive Glycemic Control: Targets the GIP and GLP-1 pathways to improve insulin sensitivity, stabilize blood sugar levels, and lower A1C, making it a potent subject for Type 2 diabetes research.

Liver Fat Reduction: Shows significant promise in reversing MASH (Fatty Liver) by rapidly clearing fat deposits within the liver.

Cardiometabolic Health: Research indicates secondary benefits including improved lipid profiles (cholesterol/triglycerides) and reduced blood pressure.